Hepion Pharmaceuticals Inc (NASDAQ: HEPA) is -52.63% lower on its value in year-to-date trading and has touched a low of $0.12 and a high of $3.49 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The HEPA stock was last observed hovering at around $0.17 in the last trading session, with the day’s gains setting it 0.05%.
Currently trading at $0.22, the stock is -46.80% and -58.33% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 314.15 million and changing 34.97% at the moment leaves the stock -73.94% off its SMA200. HEPA registered -88.52% loss for a year compared to 6-month loss of -71.99%. The firm has a 50-day simple moving average (SMA 50) of $0.54254 and a 200-day simple moving average (SMA200) of $0.864725.
The stock witnessed a -55.45% gain in the last 1 month and extending the period to 3 months gives it a -69.41%, and is -30.80% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 39.70% over the week and 21.90% over the month.
Hepion Pharmaceuticals Inc (HEPA) has around 22 employees, a market worth around $2.36M and $0.00M in sales. Distance from 52-week low is 84.05% and -93.62% from its 52-week high.
.
Hepion Pharmaceuticals Inc (HEPA) Top Institutional Holders
27.0 institutions hold shares in Hepion Pharmaceuticals Inc (HEPA), with institutional investors hold 7.85% of the company’s shares. The shares outstanding are 10.62M, and float is at 10.61M with Short Float at 1.99%. Institutions hold 7.85% of the Float.
Hepion Pharmaceuticals Inc (HEPA) Insider Activity
#####
